| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |